Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):324-6. doi: 10.1097/00126334-200403010-00017.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / blood
  • Anti-HIV Agents / isolation & purification
  • Anti-HIV Agents / therapeutic use
  • Drug Administration Schedule
  • Drug Monitoring / methods
  • Female
  • HIV Infections / blood*
  • Humans
  • Lipids / blood*
  • Lopinavir
  • Male
  • Metabolic Diseases / blood*
  • Metabolic Diseases / etiology*
  • Pyrimidinones / adverse effects*
  • Pyrimidinones / blood
  • Pyrimidinones / pharmacokinetics
  • Pyrimidinones / therapeutic use*
  • Reproducibility of Results

Substances

  • Anti-HIV Agents
  • Lipids
  • Pyrimidinones
  • Lopinavir